A medication used to treat asthma and eczema can improve survival rates for patients with moderate to severe COVID-19, a clinical trial conducted at UVA Health suggests.
Aug 11, 2022
0
92
A National Institutes of Health clinical trial has found that a monoclonal antibody, mepolizumab, decreased asthma attacks by 27% in Black and Hispanic children and adolescents who have a form of severe asthma, are prone ...
Aug 10, 2022
0
37
Asthma is a chronic condition that affects 25 million people in the United States. Having a mother with asthma is an important risk factor and a new study may explain why. A team of researchers at the University of Chicago ...
Jun 6, 2022
0
77
When taking medicine during an asthma attack, patients with the most severe form of asthma produce in their airways special substances that block the treatment from working, according to a study where Rutgers scientists collaborated ...
May 30, 2022
0
136
A global study of asthma patients by Rutgers and an international team of researchers found a combination of two drugs dramatically reduces the chances of suffering an asthma attack.
May 16, 2022
0
70
When most people think of cardiovascular diseases (CVD), risk factors such as high blood pressure, high cholesterol, obesity, and diabetes likely come to mind. But mounting evidence from both basic research and clinical studies ...
May 16, 2022
0
100
The messenger substance interleukin-3 produced by the body was previously considered to be pro-inflammatory in bronchial asthma. A research team from Universitätsklinikum Erlangen has now shown for the first time that the ...
Apr 21, 2022
0
60
A significant amount of genetic risk for asthma is likely mediated through altered gene expression within the airway epithelium. That is the conclusion of a National Jewish Health-led study to identify genetic variants that ...
Mar 28, 2022
0
68
Researchers from Indiana University School of Medicine Department of Microbiology and Immunology are studying new ways to treat seasonal or intermittent asthma. Their findings were recently published in Science Immunology.
Mar 21, 2022
0
75
Inhaled cortical steroids (ICS) can help patients manage asthma symptoms, and recent updates to asthma treatment guidelines have expanded recommended, low-dose treatment. But concerns persist that ICS may reduce production ...
Mar 21, 2022
0
171
